Published in Cancer Weekly, August 10th, 2004
For their study, the researchers first determined the presence of p53 mutations in plasma and in cancerous tissue of ovarian cancer patients. Then they "analyzed the plasma DNA for the presence of p53 mutations (exons 5-8)," they said.
"Of 27 cases of ovarian cancer, 12 cases...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.